[How can we protect against broad-band pathogens? The situation with quinolone resistance].
Kresken
M
M
Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH Immenburgstr. 20 53121 Bonn. michael.kresken@intiinfectives-intelligence.de
Hafner
D
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D004352:Drug Resistance, Microbial; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000900:Anti-Bacterial Agents; D015363:Quinolones